drugset
drugset / Trial / NCT05126979

The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years

NCT05126979 ↗

Phase 1 Completed 45 enrolled St. Petersburg Research Institute of Vaccines and Sera
RandomizedParallel-groupSingle-blindPrevention

Summary

Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years

Timeline

Start
2016-03-09
Primary completion
2016-04-25
Completion
2016-05-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Inactivated Split Influenza Vaccine Vaccine — —

Indications

influenza